Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 95899
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.95899
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.95899
Variables | n = 283 |
Recipient age (years) | 58.1 ± 9.4 |
Recipient gender | |
Female | 94 (33.2) |
Male | 189 (66.8) |
Donor age (years) | 41.6 ± 16.7 |
Donor gender | |
Female | 90 (31.8) |
Male | 193 (68.2) |
Cold ischemia time (hours) | 3.1 (2.4-3.8) |
ICU time (days) | 5 (3-7) |
Transplant day MELD | 24.2 ± 5.3 |
APACHE IV | 59.6 ± 23.4 |
APACHE IV probability of death | 2.57 (1.51-4.78) |
BAR score | 10.7 ± 3.2 |
Death in 28 days | 27 (9.5) |
Death in 90 days | 9/256 (3.5) |
1 month | 3 months | 6 months | 1 year | 2 years | 3 years | 4 years | 5 years | |
Survival rate (%) | 90.1 | 87.6 | 85.9 | 82.5 | 79.6 | 78.2 | 78.2 | 78.2 |
Variables | Death in 28 days | Death in 90 days | ||||||||||
AUC | 95%CI | P value | Cutoff point | Sensitivity | Specificity | AUC | 95%CI | P value | Cutoff point | Sensitivity | Specificity | |
APACHE IV | 0.85 | 0.76-0.94 | < 0.001 | 71.50 | 77.80% | 83.20% | 0.80 | 0.71-0.90 | < 0.001 | 64.50 | 77.80% | 72.10% |
BAR score | 0.70 | 0.58-0.81 | 0.001 | 10.50 | 66.70% | 55.90% | 0.66 | 0.55-0.77 | 0.004 | 10.50 | 61.10% | 55.90% |
MELD | 0.66 | 0.55-0.78 | 0.006 | 24 | 77.80% | 35.20% | 0.62 | 0.51-0.72 | 0.026 | 24 | 75.00% | 35.20% |
Variables | Death in 28 days | Death in 90 days | Death | ||||||
Yes | No | P value | Yes | No | P value | Yes | No | P value | |
Recipient's age | 59.2 ± 12.1 | 58.0 ± 9.1 | 0.604 | 62.4 ± 7.0 | 57.8 ± 9.2 | 0.135 | 59.3 ± 9.3 | 57.8 ± 9.5 | 0.275 |
ICU stay time | 5 (3-8) | 5 (3-7) | 0.603 | 5 (4.5-18) | 5 (3-7) | 0.114 | 5 (3-10) | 5 (3-7) | 0.130 |
Cold ischemia time | 3.3 (2.4-4.2) | 3.1 (2.4-3.8) | 0.634 | 2.9 (1.6-3.4) | 3.1 (2.4-3.8) | 0.208 | 3.3 (2.5-3.8) | 3.1 (2.4-3.8) | 0.571 |
APACHE IV points | 92.0 ± 32.1 | 56.1 ± 19.4 | < 0.001 | 86.1 ± 32.5 | 55.7 ± 18.9 | < 0.001 | 76.5 ± 30.4 | 55.2 ± 19.0 | < 0.001 |
APACHE IV prob death | 13.4 (4.6-26.9) | 2.4 (1.4-4.1) | < 0.001 | 11.6 (3.6-25.3) | 2.3 (1.4-3.9) | < 0.001 | 4.9 (2.2-18.7) | 2.3 (1.4-3.9) | < 0.001 |
BAR | 13.2 ± 4.1 | 10.5 ± 2.9 | 0.002 | 12.7 ± 4.1 | 10.5 ± 2.9 | 0.003 | 11.8 ± 3.8 | 10.5 ± 2.9 | 0.016 |
MELD | 28.3 ± 8.1 | 23.7 ± 4.7 | 0.008 | 27.1 ± 7.7 | 23.7 ± 4.7 | 0.016 | 26.1 ± 6.7 | 23.7 ± 4.8 | 0.013 |
- Citation: Hohenreuther R, Silveira AT, Filho EMR, Garcez A, Lacerda BG, Fernandes SA, Marroni CA. Physiology and health assessment, risk balance, and model for end-stage liver disease scores: Postoperative outcome of liver transplantation. World J Transplant 2025; 15(1): 95899
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/95899.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.95899